$15.49
-0.27-1.71%
Last update: Dec 16, 10:13 AM
Comments
Loading...
10x Genomics Stock Guidance | NASDAQ:TXG | Benzinga
10x Genomics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/06/2025 | TXG | 10x Genomics | Q4 | 2025 | — | — | — | $154.00M | $158.00M | $142.47M | Get Alert |
| 08/07/2025 | TXG | 10x Genomics | Q3 | 2025 | — | — | — | $140.00M | $144.00M | $139.48M | Get Alert |
| 05/08/2025 | TXG | 10x Genomics | Q2 | 2025 | — | — | — | $138.00M | $142.00M | $145.59M | Get Alert |
| 02/12/2025 | TXG | 10x Genomics | FY | 2025 | — | — | — | $610.00M | $630.00M | $630.36M | Get Alert |
| 01/13/2025 | TXG | 10x Genomics | FY | 2024 | — | — | — | $611.00M | $611.00M | $610.80M | Get Alert |
| 10/29/2024 | TXG | 10x Genomics | FY | 2024 | — | — | — | $595.00M | $605.00M | $636.59M | Get Alert |
| 10/09/2024 | TXG | 10x Genomics | Q3 | 2024 | — | — | — | $151.70M | $151.70M | $162.24M | Get Alert |
| 08/08/2024 | TXG | 10x Genomics | FY | 2024 | — | — | — | $640.00M | $660.00M | $663.06M | Get Alert |
| 04/30/2024 | TXG | 10x Genomics | FY | 2024 | — | — | — | $670.00M | $690.00M | $677.79M | Get Alert |
| 02/15/2024 | TXG | 10x Genomics | FY | 2024 | — | — | — | $670.00M | $690.00M | $702.06M | Get Alert |
| 01/08/2024 | TXG | 10x Genomics | FY | 2023 | — | — | — | $618.70M | $618.70M | $614.69M | Get Alert |
| 01/08/2024 | TXG | 10x Genomics | Q4 | 2023 | — | — | — | $184.00M | $184.00M | $179.70M | Get Alert |
| 11/02/2023 | TXG | 10x Genomics | FY | 2023 | — | — | — | $610.00M | $625.00M | $608.22M | Get Alert |
| 08/03/2023 | TXG | 10x Genomics | FY | 2023 | — | — | — | $600.00M | $620.00M | $600.73M | Get Alert |
| 05/03/2023 | TXG | 10x Genomics | FY | 2023 | — | — | — | $590.00M | $610.00M | $593.20M | Get Alert |
| 02/15/2023 | TXG | 10x Genomics | FY | 2023 | — | — | — | $580.00M | $600.00M | $613.96M | Get Alert |
| 11/02/2022 | TXG | 10x Genomics | FY | 2022 | — | — | — | $500.00M | $520.00M | $509.87M | Get Alert |
| 08/08/2022 | TXG | 10x Genomics | FY | 2022 | — | — | — | $500.00M | $520.00M | $571.06M | Get Alert |
| 07/14/2022 | TXG | 10x Genomics | Q2 | 2022 | — | — | — | $114.50M | $114.50M | $127.70M | Get Alert |
| 05/04/2022 | TXG | 10x Genomics | FY | 2022 | — | — | — | $600.00M | $630.00M | $614.05M | Get Alert |
| 02/16/2022 | TXG | 10x Genomics | FY | 2022 | — | — | — | $600.00M | $630.00M | $679.87M | Get Alert |
FAQ
Q
What is the most recent guidance for 10x Genomics (TXG)?
A
There have been no specific sales or earnings guidance reported for 10x Genomics in recent months.
Browse guidance and forecast on all stocks.
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved